Obesity and diabetes continue to climb across Colorado. In El Paso County, nearly 23% of adults are affected by obesity—and recent estimates place rates above 25%—while chronic conditions such as diabetes continue to pose growing public health concerns. For Colorado Springs locals, health challenges often stem from everyday realities: long I-25 commutes, calorie-heavy festivals downtown, and limited outdoor activity during long snowy winters.
Our Colorado Springs retatrutide clinic offers a science-backed, sustainable solution. Retatrutide, created by Eli Lilly, is a triple hormone receptor agonist that works through GLP-1, GIP, and glucagon pathways. This triple-action peptide reduces appetite, balances blood sugar, and boosts fat metabolism. In clinical studies, patients achieved up to 24% body weight loss on average.
Start building momentum toward your goals — book your free weight loss consultation in Colorado Springs today.
We provide care throughout the metro area with both in-person and telehealth visits:
Patients often ask how semaglutide vs retatrutide or tirzepatide vs retatrutide compare. Here’s a breakdown:
| Feature / Pathway | Semaglutide | Tirzepatide | Retatrutide |
|---|---|---|---|
| Pathways Activated | GLP-1 only | GLP-1 + GIP | GLP-1 + GIP + Glucagon |
| Avg. Weight Loss (48 wks) | ~15% | ~21% | ~24% |
| Lifestyle Impact | Appetite control only; plateaus for many. | Helps stabilize sugar and portions. | Triple pathway activation has shown to offer a more comprehensive approach to weight and metabolic control which proves to provide superior results than single or dual-agonist therapies. |
GLP‑1: Suppresses appetite and slows digestion so you feel full longer.
GIP: Stimulates insulin release and supports better glucose control.
Glucagon receptor activation: Boosts fat metabolism and increases calorie burn.
This triple action means Retatrutide can help patients see faster, more substantial weight loss while maintaining muscle mass.
GLP-1 (Satiety Control):
Prevents overindulgence at Broadmoor brunches.
GIP (Insulin Sensitivity):
Balances blood sugar after chili cook-offs or Territory Days.
Glucagon (Fat Metabolism):
Supports fat burn when Garden of the Gods trails are snow-packed.
Your first retatrutide injections Colorado Springs visit includes:
Reserve your free consultation today — appointments fill quickly.
Eligibility Review:
Medical clearance and BMI check.
Personalized Dosing Plan:
MD-supervised, designed around active residents (skiing, hiking, or late-night work schedules).
Injection Training + Lifestyle Prep:
Offered in-person or telehealth for Falcon and Briargate patients, with hydration strategies for dry altitude.
Ongoing Lifestyle Coaching:
Nutrition and activity guidance for festival-heavy weekends and altitude challenges.
Monthly Check-Ins:
Nurse-led accountability, even during deployments or frequent business travel.
Months 1–3:
Noticeable reduced cravings and improved portion control resulting to early weight loss of 3–6% body weight.
Months 4–6:
Fat loss accelerates with 8–12% body weight reduction. Many patients experience stabilized blood sugar levels and changes in clothing fit.
Months 6–12:
Up to 24% reduction in body weight; stamina improves for marathons, ski trips, and mountain hikes.
Most patients adjust well, though temporary nausea or digestive changes may occur. Here’s how locals adapt:
Months 1–3:
Noticeable reduced cravings and improved portion control resulting to early weight loss of 3–6% body weight.
Months 4–6:
Fat loss accelerates with 8–12% body weight reduction. Many patients experience stabilized blood sugar levels and changes in clothing fit.
Months 6–12:
Up to 24% reduction in body weight; stamina improves for marathons, ski trips, and mountain hikes.
Pricing depends on dose and program length. Your consultation includes a full cost review.
New England Journal of Medicine retatrutide trial — up to 24.2% weight loss in 48 weeks.
American Diabetes Association retatrutide study — significant improvements in blood sugar control.
Eli Lilly clinical program — ongoing multi-condition research.
Retatrutide is considered next-generation because it targets three hormone receptors involved in appetite control, glucose metabolism, and energy regulation. This multi-receptor approach is being studied for its potential to address complex metabolic resistance.
Unlike single-pathway therapies, Retatrutide is designed to influence several biological signals at once. Treatment decisions are based on clinical evaluation and individualized metabolic assessment.
Retatrutide works by influencing hormones that regulate how the body processes food and stores energy. It may help improve insulin response and reduce persistent hunger signals that contribute to weight gain.
Metabolic therapy is approached carefully and under medical supervision. In Colorado Springs, treatment plans are developed based on each patient’s health profile and long-term goals.
Some patients experience metabolic plateaus despite consistent diet and exercise. Retatrutide is being studied for its potential to address hormonal factors that may contribute to stalled progress.
A medical evaluation is required to determine whether metabolic therapy is appropriate. Providers assess weight history, lifestyle patterns, and underlying health conditions before recommending treatment.
Dosing is individualized and typically begins at a lower level before gradually increasing. This stepwise approach may help improve tolerance and reduce the likelihood of side effects.
Providers in Colorado Springs monitor response closely and adjust dosing based on clinical progress and patient feedback.
Clinical research has reported gastrointestinal symptoms such as nausea, decreased appetite, and mild digestive discomfort. These effects are often temporary and may improve with gradual dose adjustments.
Patients are counseled on expected responses and monitored regularly to ensure safety. Any unusual or persistent symptoms should be discussed with a provider.
No. Retatrutide is typically incorporated into a structured medical weight management plan that includes nutritional planning and physical activity guidance.
Medication may support appetite regulation, but sustainable results depend on consistent lifestyle integration and ongoing medical oversight.
Research is exploring the medication’s impact on body composition, including reductions in overall fat mass. Weight loss may contribute to improvements in metabolic markers associated with visceral fat.
However, body composition changes vary between individuals. Monitoring and realistic expectations are part of the treatment process.
Follow-up appointments focus on tracking weight trends, symptom tolerance, and overall metabolic response. Providers may adjust dosage or discuss additional lifestyle recommendations.
Regular follow-up supports safety, structured progress, and long-term planning rather than short-term rapid results.
Retatrutide is being studied for weight management regardless of diabetes status. However, eligibility depends on BMI, overall health, and risk factors evaluated during consultation.
Patients without diabetes must still undergo full screening to determine whether therapy is appropriate for their clinical profile.
The first step is scheduling a medical consultation. During this visit, a licensed provider reviews your health history, weight goals, and metabolic indicators.
If appropriate, a personalized treatment plan is created with structured monitoring and follow-up. All prescriptions are provided under medical supervision to prioritize safety and responsible care.
